A large number of genomic studies have reported associations between the gut microbiota composition and metabolic diseases such as obesity or type 2 diabetes. This led to the widespread idea that a causal relationship could exist between intestinal microbiota and metabolic diseases. At odds with this idea, some compelling studies reported that global changes in microbiota composition have no effect on the host metabolism in obese mice or humans. However, specific bacteria are able to confer host metabolic benefits, such as Akkermansia muciniphila or Prevotella copri, when they are given by gavage in obese mice. A crucial link by which gut bacteria communicate with the host mucosa is based on metabolites or low-molecular-weight compounds. Among them, short-chain fatty acids produced from the fermentation of dietary fibers initiate beneficial effects on the host metabolism via the activation of intestinal gluconeogenesis (a mucosal function exerting antidiabetic and antiobesity effects through the activation of gut-brain neural circuits). However, fermentation of short-chain fatty acids is a function that is widespread among the main bacterial phyla and thus weakly depends on microbiota composition. Therefore, even if some bacteria may confer on the host metabolic benefits, the causal role of microbiota in metabolic diseases is not established.

Keywords:
Obesity, Metabolic control, Intestinal mucosa, Gut microbiota, Dietary intervention, Soluble fibers, Short-chain fatty acids, Intestinal gluconeogenesis
1.
Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI: Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008;3:213-223.
2.
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013;110:9066-9071.
3.
De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, et al: Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014;156:84-96.
4.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031.
5.
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al: Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-563.
6.
Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al: Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-546.
7.
Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015;528:262-266.
8.
Rieder R, Wisniewski PJ, Alderman BL, Campbell SC: Microbes and mental health: a review. Brain Behav Immun DOI: 10.1016/j.bbi.2017.01.016.
9.
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E: Dysbiosis and the immune system. Nat Rev Immunol 2017;17:219-232.
10.
Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S: Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci DOI: 10.1007/s00018-017-2550-9.
11.
Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al: Dietary intervention impact on gut microbial gene richness. Nature 2013;500:585-588.
12.
Simpson HL, Campbell BJ: Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther 2015;42:158-179.
13.
Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T, et al: Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab 2015;22:971-982.
14.
Mendeloff AI: Dietary fiber and human health. N Engl J Med 1977;297:811-814.
15.
Harley IT, Giles DA, Pfluger PT, Burgess SL, Walters S, Hembree J, et al: Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice. Mol Metab 2013;10:171-183.
16.
Reijnders D, Goossens GH, Hermes GD, Neis EP, van der Beek CM, Most J, et al: Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial. Cell Metab 2016;24:63-74.
17.
Obata Y, Pachnis V: The effect of microbiota and the immune system on the development and organization of the enteric nervous system. Gastroenterology 2016;151:836-844.
18.
Kabouridis PS, Pachnis V: Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system. J Clin Invest 2015;125:956-964.
19.
Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP: Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci 2015;9:392.
20.
Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, et al: Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism. Mol Syst Biol 2017;13:921.
21.
Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, et al: A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in mice. Nat Med 2017;23:107-113.
22.
De Vadder F, Kovatcheva-Datchary P, Zitoun C, Duchampt A, Bäckhed F, Mithieux G: Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metab 2016;24:151-157.
23.
Soty M, Gautier-Stein A, Rajas F, Mithieux G: Gut-brain glucose signaling in energy homeostasis. Cell Metab 2017;25:1231-1242.
24.
Mazmanian SK, Round JL, Kasper DL: A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008;453:620-625.
25.
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al: Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155:1451-1463.
26.
Mithieux G: Metabolic effects of portal vein sensing. Diabetes Obes Metab 2014;16:56-60.
27.
Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, et al: Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 2014;8:1323-1335.
28.
Macfarlane GT, Macfarlane S: Bacteria, colonic fermentation and gastrointestinal health. J AOAC Int 2012;95:50-60.
29.
Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F: from dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016;165:1332-1345.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.